Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,138.80
(
-0.49%
)
US TECH 100
26,370.40
(
0.26%
)
Dow Jones
49,141.93
(
-0.34%
)
Brent Oil
107.82
(
3.26%
)
Bitcoin
76,992.24
(
0.85%
)
News Focus
News Focus
Post# of 20689
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

jbog

Send PM Follow Ignore
Followers 64
Posts 11879
Boards Moderated 0
Alias Born 07/16/2006

jbog

Re: alternatepatel post# 17573

Thursday, 08/10/2017 10:07:54 AM

Thursday, August 10, 2017 10:07:54 AM

Post# of 20689
I have a suspicion that both Momenta and Mylan will get approval around the same timeframe. With that said the question is if Sandoz/Momenta/Pfizer can be price competitive with Teva or Mylan/Natco.

If Enoxaparin is any guide it doesn't bode well.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote